Evidence map›Paper›PMID 29854805›Full record

ArticleBioMed research international2018

Biomimetic Implant Surface Functionalization with Liquid L-PRF Products: In Vitro Study.

Marco Lollobrigida, Manuela Maritato, Giuseppina Bozzuto, Giuseppe Formisano, Agnese Molinari, Alberto De Biase

Abstract read
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. [Research progress on platelet-rich fibrin derivatives].Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2019
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marco LollobrigidaDepartment of Oral and Maxillofacial Sciences, Sapienza University of Rome, Rome, Italy.ORCID 0000-0001-8182-5618
Manuela MaritatoPrivate Practice, Rome, Italy.
Giuseppina BozzutoNational Centre of Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
Giuseppe FormisanoNational Centre of Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
Agnese MolinariNational Centre of Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
Alberto De BiaseDepartment of Oral and Maxillofacial Sciences, Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-8475-463X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePlatelet-rich fibrin (PRF) clots and membranes are autologous blood concentrates widely used in oral surgical procedures; less is known, however, about the liquid formulations of such products. The aim of this in vitro study is to assess the behavior of different implant surfaces when in contact with two liquid leucocyte- and platelet-rich fibrin (L-PRF) products.

methodsSix commercial pure titanium discs, of 9.5 mm diameter and 1.5 mm thickness, were used. Three of these samples had a micro/nano-rough surface; three were machined. Three different protocols were tested. Protocols involved the immersion of the samples in (1) a platelets, lymphocytes, and fibrinogen liquid concentrate (PLyF) for 10 minutes, (2) an exudate obtained from L-PRF clots rich in fibronectin and vitronectin for 5 minutes, and (3) the fibronectin/vitronectin exudate for 2 minutes followed by immersion in the PLyF concentrate for further 8 minutes. After these treatments, the samples were fixed and observed using a scanning electron microscope (SEM).

resultsUnder microscopic observation, (1) the samples treated with the PLyF concentrate revealed a dense fibrin network in direct contact with the implant surface and a significant number of formed elements of blood; (2) in the samples treated with the fibronectin/vitronectin exudates, only a small number of white and red blood cells were detectable; and (3) in samples exposed to the combined treatment, there was an apparent increase in the thickness of the fibrin layer. When compared to the machined surface, the micro/nano-rough samples showed an overall increased retention of fibrin, leading to a thicker coating.

conclusionsLiquid L-PRF products promote the formation of a dense fibrin clot on micro/nano-rough implant surfaces in vitro. The adjunctive treatment of surfaces with the fibronectin/vitronectin exudate could provide support to contact of the fibrin with the surface, though it is not essential for the clot formation. Further studies are necessary to better elucidate the properties and benefits of liquid L-PRF products.

Indexed as

BiomimeticsBlood CoagulationBlood PlateletsFibrinFibronectinsHumansLeukocytesLymphocytesPlatelet-Rich FibrinProstheses and ImplantsVitronectinFibrinFibronectinsVitronectin

Identifiers

PMID29854805
PMCPMC5964419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.